In dermatology, prior authorizations (PAs) have become a common administrative tool that payers use to manage the utilization of biologics and other expensive therapies.1 PAs require physicians to obtain pretreatment approval from a patient’s insurer for the reimbursement of a specific drug or service. PAs are meant to control costs by preventing the inappropriate use of medical resources.
Andrew T. Rogers, Brittany Sutherland, Manisha J. Loss. Prior Authorizations for Diagnostic Skin BiopsiesDoes Anyone Benefit?. JAMA Dermatol. 2017;153(11):1091–1092. doi:10.1001/jamadermatol.2017.3516